Adjuvant RT May Aid Men at High Risk for Death From Prostate Cancer
Adjuvant RT versus early salvage RT may lower the risk for all-cause mortality in men with adverse pathology at radical prostatectomy
Survival Examined for Early-Onset Colorectal Cancer
Survival advantage greatest for diagnosis at age 35 through 39 years with stage I or II disease versus diagnosis at age 51 to 55 years
Stressors of Integrating Work, Life Higher for Female Faculty
Since COVID-19, faculty more likely to consider leaving, reducing employment, especially female faculty members
AMA: 96 Percent of Physicians Fully Vaccinated Against COVID-19
No significant differences seen in physician vaccination rates across demographic groups, including region, gender, age
Many Older Women Not Eligible to Quit Cervical Cancer Screening
Findings consistent among women with employer-based insurance and those treated at a safety net health center
Financial Toxicity More Prevalent for ASCVD Than Cancer Patients
Odds up for any difficulty paying medical bills, inability to pay bills, cost-related meds nonadherence, food insecurity with ASCVD versus cancer
Convalescent Plasma Use Inversely Linked to COVID-19 Mortality
Reduction in CCP use may have resulted in 29,000 excess deaths in the U.S. from mid-November 2020 to February 2021
Adjuvant Nivolumab Slows Muscle-Invasive Urothelial Carcinoma
Disease-free survival was longer with adjuvant nivolumab in intention-to-treat population, for those with PD-L1 expression at least 1 percent
Judge Dismisses Lawsuit Over Hospital’s COVID-19 Vaccine Policy
Lawsuit was signed by 117 of 178 workers who were suspended last week for failure to get fully vaccinated by the hospital's deadline
